Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract.
Cancers of the anogenital tract as well as some head and neck cancers are caused by persistent infections with high-risk type human papillomaviruses (HPVs). Two viral oncogenes, E6 and E7, induce severe chromosomal instability associated with centrosome aberrations, anaphase bridges, chromosome lagging, and breaking. This occurs early in preneoplastic lesions, when the viral genome still persists in an episomal state. In most invasive cancers and also in a few high-grade dysplastic lesions, however, integration of high-risk HPV genomes into the host genome is observed. Integration seems to be a direct consequence of chromosomal instability and an important molecular event in the progression of preneoplastic lesions. Disruption or deregulation of defined critical cellular gene functions by insertional mutagenesis by integrated HPV genome fragments has been hypothesized as one major promoting factor in the pathogenesis of HPV-associated cancers. This hypothesis was based on the detection of HPV integration events in the area of tumor-relevant genes in few cases. Here, we reviewed >190 reported integration loci with respect to changes in the viral structure and the targeted genomic locus. This analysis confirms that HPV integration sites are randomly distributed over the whole genome with a clear predilection for genomic fragile sites. No evidence for targeted disruption or functional alteration of critical cellular genes by the integrated viral sequences could be found.
Wentzensen
Nicolas
N
Institute of Molecular Pathology, Department of Pathology, Heidelberg, Germany.
Vinokurova
Svetlana
S
von Knebel Doeberitz
Magnus
M
D002472:Cell Transformation, Viral / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics; D004847:Epithelial Cells / Q000473:pathology / Q000821:virology; D005260:Female; D015967:Gene Expression Regulation, Viral; D005833:Genital Neoplasms, Female / Q000235:genetics* / Q000821:virology*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D027383:Papillomaviridae / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000821:virology; D014625:Vaginal Neoplasms / Q000235:genetics / Q000821:virology; D016662:Virus Integration / Q000235:genetics*; D014846:Vulvar Neoplasms / Q000235:genetics / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000235:genetics / Q000821:virology
D004279:DNA, Viral